Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: Interactions with adiponectin levels

European Journal of Endocrinology

Volumn 161, Issue 1, 2009, Pages 81-85

  Bonnet, Fabrice ^a,f   Balkau, B ^a   Malekot J M ^a   Picard, P ^a   Lange, C ^a   Fumeron, F ^a,g   Auvert, R ^a   Raverot, V ^b   Dechaud H ^b   Tichet, J ^c,j   Lecomte, P ^d   Pugeat, M ^e   Ducimetiere P ^a   Echwege E ^a   Alhenc Gelas, F ^a   Gallois, Y ^g   Girault, A ^g   Marre, M ^h   Froguel, P ⁱ   Cogneau, J ^{j,k,l,m,n,o,p,q}   Born, C ^r   Caces, E ^r   Cailleau, M ^r   Moreau, J G ^r   Rakotozafy, F ^r   Vol, S ^r   more..

^a INSERM   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c IRSA   (France)

^d CHU BRETONNEAU   (France)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g ANGERS UNIVERSITY HOSPITAL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ Institut Pasteur de Lille   (France)

^j Centres d'Examens de Santé   (France)

^k Institut inter Régional pour la Santé   (France)

^l Centres D'examens de Santé   (France)

^m Centres d'Examens de Santé   (France)

ⁿ Institut inter Régional pour la Santé   (France)

^o Institute de Recherche Médecine Générale ^*  (France)

^p Centres d'Examens de Santé Alençon   (France)

^q Institute de Recherche Médecine Générale   (France)

^r Institute Intern Regional pour la Santé

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; ADIPONECTIN, HUMAN;

ADULT; ANALYTIC METHOD; ARTICLE; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE INDEX; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; BODY MASS; COMPARATIVE STUDY; INCIDENCE; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; PREVALENCE; PROSPECTIVE STUDY; SEX RATIO; SEXUAL DEVELOPMENT;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; SEX HORMONE-BINDING GLOBULIN;

EID: 67650770668     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0202     Document Type: Article

References (18)

1. Plymate SR, Matej LA, Jones RE & Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. Journal of Clinical Endocrinology and Metabolism 1988 67 460-464.
2. Yki-Jarvinen H, Makimattila S, Utriainen T & Rutanen EM. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. Journal of Clinical Endocrinology and Metabolism 1995 80 3227-3232.
3. Haffner SM, Valdez RA, Morales PA, Hazuda HP & Stern MP. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. Journal of Clinical Endocrinology and Metabolism 1993 77 56-60.
4. Ding EL, Song Y, Malik VS & Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2006 295 1288-1299.
5. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H & Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003 361 226-228.
6. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
7. Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M & Pugeat M. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 3626-3631.
8. Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S, Tichet J, Wilpart E, Chesnier MC, Balkau B, Froguel P & Marre M. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004 53 1150-1157.
9. Charles MA & Balkau B. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197.
10. Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, Czernichow S, Fumeron F, Froguel P, Vaxillaire M, Cauchi S, Ducimetiere P & Eschwege E. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2008 31 2056-2061.
11. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C & Bjorntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM, 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991 40 123-128.
12. Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune H, Dechaud H & Tourniaire J. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. Journal of Steroid Biochemistry and Molecular Biology 1991 40 841-849.
13. Selva DM, Hogeveen KN, Innis SM & Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. Journal of Clinical Investigation 2007 117 3979-3987.
14. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ & Lam KS. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. Journal of Biological Chemistry 2005 280 18073-18080.
15. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, Metzger J, Schweigert FJ, Luppa PB, Nykjaer A & Willnow TE. Role of endocytosis in cellular uptake of sex steroids. Cell 2005 122 751-762.
16. Haffner SM, Shaten J, Stern MP, Smith GD & Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men, MRFIT Research Group. Multiple Risk Factor Intervention Trial. American Journal of Epidemiology 1996 143 889-897.
17. Stellato RK, Feldman HA, Hamdy O, Horton ES & McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000 23 490-494.
18. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ & McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism 2006 91 843-850.